While RxSight Inc has overperformed by 3.47%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, RXST fell by -72.48%, with highs and lows ranging from $66.54 to $14.37, whereas the simple moving average fell by -62.93% in the last 200 days.
On Apr-10-25, UBS Downgraded RxSight Inc (NASDAQ: RXST) to Neutral. A report published by JP Morgan on April 04, 2025, Downgraded its rating to ‘Underweight’ for RXST. BofA Securities also Downgraded RXST shares as ‘Underperform’, setting a target price of $22 on the company’s shares in a report dated April 03, 2025. Stifel December 20, 2024d the rating to Hold on December 20, 2024, and set its price target from $65 to $40. Wells Fargo December 11, 2024d its ‘Overweight’ rating to ‘Equal Weight’ for RXST, as published in its report on December 11, 2024. UBS’s report from December 06, 2024 suggests a price prediction of $52 for RXST shares, giving the stock a ‘Buy’ rating. Jefferies also rated the stock as ‘Buy’.
Analysis of RxSight Inc (RXST)
Further, the quarter-over-quarter increase in sales is 40.71%, showing a positive trend in the upcoming months.
In order to gain a clear picture of RxSight Inc’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of -12.43% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 10.50, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 751.20K can be a very valuable indicator of volatility for RXST stock. On a monthly basis, the volatility of the stock is set at 6.72%, whereas on a weekly basis, it is put at 14.29%, with a loss of -40.62% over the past seven days. Furthermore, long-term investors anticipate a median target price of $25.00, showing growth from the present price of $15.51, which can serve as yet another indication of whether RXST is worth investing in or should be passed over.
How Do You Analyze RxSight Inc Shares?
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 5.20%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 87.21% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
RXST shares are owned by institutional investors to the tune of 87.21% at present.
